Effect of blocking oestrogen synthesis with a new generation aromatase inhibitor CGS 16949A on follicular maturation induced by pregnant mare serum gonadotrophin in the immature rat.
While the endocrine role of oestrogen is well established, its function in follicular maturation as an autocrine or paracrine regulator is less well understood. This study was designed to delineate the requirement of oestrogen for follicular development in immature rats. Exogenous gonadotrophin (25 IU pregnant mare serum gonadotrophin (PMSG) per rat) was administered to 21- to 23-day old female rats to induce follicular growth and development. In the experimental animals, synthesis of oestrogen was blocked by implanting an Alzet pump containing the aromatase inhibitor (AI) CGS 16949A (fadrozole hydrochloride; 50 micrograms/rat per day). The treatment resulted in blockade of the PMSG induced increase in both serum and intrafollicular oestrogen (> 95%), thus leading to an inhibition in uterine weight increment. Compared with the controls, ovarian weight increased markedly in both the PMSG (295%)- and PMSG+AI (216%)-primed animals. There was no significant difference in either the proliferative capabilities of the ovarian granulosa cells or their responsiveness to human chorionic gonadotrophin (hCG; 200 pg/ml) and ovine FSH (20 ng/ml) between the PMSG- and PMSG+AI-treated groups. Histological examination of the ovary, however, indicated a decrease in the number of healthy antral follicles in the AI-treated group compared with the PMSG-primed animals but both the groups showed a percentage increase over the controls (PMSG, 225; PMSG+AI, 158). The responsiveness of the animals to an ovulatory dose of hCG was drastically reduced (> 80% inhibition of ovulation) in the oestrogen-deprived animals; this could be overriden by exogenous administration of oestrogen.(ABSTRACT TRUNCATED AT 250 WORDS)
Selvaraj
N
N
Department of Biochemistry, Indian Institute of Science, Bangalore.
Shetty
G
G
Vijayalakshmi
K
K
Bhatnagar
A S
AS
Moudgal
N R
NR
D000818:Animals; D047072:Aromatase Inhibitors; D002478:Cells, Cultured; D004967:Estrogens / Q000378:metabolism / Q000502:physiology*; D017316:Fadrozole / Q000494:pharmacology*; D005260:Female; D006064:Gonadotropins, Equine / Q000494:pharmacology*; D006107:Granulosa Cells / Q000187:drug effects; D009929:Organ Size / Q000187:drug effects; D006080:Ovarian Follicle / Q000187:drug effects / Q000378:metabolism / Q000502:physiology*; D010053:Ovary / Q000033:anatomy & histology; D051381:Rats; D017208:Rats, Wistar
D047072:Aromatase Inhibitors; D004967:Estrogens; D006064:Gonadotropins, Equine; D017316:Fadrozole